A Review of Cardiac and Non-Cardiac Causes of Troponin Elevation and Clinical Relevance Part II: Non Cardiac Causes

Cardiac troponin T (cTnT) and troponin I (cTnI) are cardiac regulatory proteins that control the calcium mediated interaction between actin and myosin [1]. The troponin complex consists of three subunits: troponin C, troponin I, and troponin T. This complex is located on the myofibrillar thin (actin) filament of striated (skeletal and cardiac) muscle. The cardiac isoforms troponin T and I are only expressed in cardiac muscle [1].

• Publication year

  2018

• Venue

  Journal of Cardiology & Current Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.15406/jccr.2017.10.00360
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Microvascular dysfunction in infiltrative cardiomyopathies

  2019cited by this paper
• Pre‐discharge and early post‐discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial

  2018influential reference
• Recent advances in diagnosis and treatment of cardiac amyloidosis.

  2018cited by this paper
• High-Sensitivity Troponin as a Biomarker in Heart Rhythm Disease.

  2017cited by this paper
• Association of Troponin Trends and Cardiac Morbidity and Mortality After On-Pump Cardiac Surgery.

  2017cited by this paper
• A multimarker multi‐time point‐based risk stratification strategy in acute heart failure: results from the RELAX‐AHF trial

  2017cited by this paper
• Restrictive Cardiomyopathy

  2017cited by this paper
• Troponin I elevation and all-cause mortality after elective percutaneous coronary interventions.

  2017cited by this paper
• Cardiac troponins: from myocardial infarction to chronic disease

  2017cited by this paper
• Blunt and Penetrating Cardiac Trauma.

  2017influential reference
• In search of an efficient strategy to monitor disease status of chronic heart failure outpatients: added value of blood biomarkers to clinical assessment

  2017cited by this paper
• High-Sensitivity Cardiac Troponin for the Diagnosis of Patients with Acute Coronary Syndromes

  2017influential reference
• Cardiac troponin and outcome in decompensated heart failure with preserved ejection fraction.

  2017cited by this paper
• Sex‐based differences in prevalence and clinical presentation among pericarditis and myopericarditis patients☆,☆☆,★,★★

  2017cited by this paper
• Evaluation of Myocardial Injury using Standard Diagnostic Tools and Tissue Doppler Imaging in Blunt Trauma Chest.

  2017cited by this paper
• Predictors of significant coronary artery disease in atrial fibrillation: Are cardiac troponins a useful measure.

  2016cited by this paper
• Biomarkers Investigation for In-Hospital Death in Patients With Stanford Type A Acute Aortic Dissection.

  2016cited by this paper
• Potentially missed acute pericarditis: atypical pericarditis.

  2016cited by this paper
• Myocardial injury during radiofrequency and cryoablation of typical atrial flutter

  2016cited by this paper
• Prognostic effect of cardiac troponin elevation in acute aortic dissection: A meta-analysis.

  2016influential reference
• High‐Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease

  2016cited by this paper
• Early release of high-sensitive cardiac troponin during complex catheter ablation for ventricular tachycardia and atrial fibrillation

  2016cited by this paper
• Electrocardiography changes in acute aortic dissection-association with troponin leak, coronary anatomy, and prognosis.

  2016cited by this paper
• Identifying the broken heart: predictors of mortality and morbidity in suspected blunt cardiac injury.

  2016cited by this paper
• Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association

  2016cited by this paper
• The universal definition of myocardial infarction

  2015cited by this paper
• Plasma ultrasensitive cardiac troponin during long-term follow-up of heart transplant recipients.

  2015cited by this paper
• Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy.

  2015cited by this paper
• Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX‐AHF study

  2015cited by this paper
• Usefulness of Cardiac Troponins as Markers of Early Treatment Response in Cardiac Sarcoidosis.

  2015cited by this paper
• Stress-Induced Cardiomyopathy

  2015cited by this paper
• Cardiac troponin levels following implantable cardioverter defibrillation implantation and testing.

  2015cited by this paper
• Incidence and angiographic characteristics of patients With apical ballooning syndrome (takotsubo/stress cardiomyopathy) in the HORIZONS‐AMI trial

  2014cited by this paper
• Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays

  2014cited by this paper
• Prognostic evaluation of the troponin I elevation after multiple spontaneous shocks of the implantable cardioverter/defibrillator.

  2014cited by this paper
• Myocardial damage influences short- and mid-term survival after valve surgery: a prospective multicenter study.

  2014cited by this paper
• Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary.

  2014influential reference
• Good Prognosis for Pericarditis With and Without Myocardial Involvement: Results From a Multicenter, Prospective Cohort Study

  2013cited by this paper
• Current state of cardiac amyloidosis

  2013cited by this paper
• The third universal definition of myocardial infarction

  2013cited by this paper
• Troponin I in acute decompensated heart failure: insights from the ASCEND‐HF study

  2012cited by this paper
• Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section.

  2012cited by this paper
• Angiographic investigation of the pathophysiology of perioperative myocardial infarction

  2012influential reference
• Serial Measurement of Cardiac Troponin T Using a Highly Sensitive Assay in Patients With Chronic Heart Failure: Data From 2 Large Randomized Clinical Trials

  2012cited by this paper
• Usefulness of high-sensitive cardiac troponin T for evaluating the activity of cardiac sarcoidosis.

  2012cited by this paper
• Soluble ST2, high‐sensitivity troponin T‐ and N‐terminal pro‐B‐type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure

  2011cited by this paper
• Impact of Serial Troponin Release on Outcomes in Patients With Acute Heart Failure: Analysis From the PROTECT Pilot Study

  2011cited by this paper
• Pathogenesis of the Takotsubo syndrome: a unifying hypothesis.

  2010cited by this paper
• Troponin elevation in heart failure prevalence, mechanisms, and clinical implications.

  2010cited by this paper
• Infiltrative cardiovascular diseases: cardiomyopathies that look alike.

  2010cited by this paper
• Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure.

  2009cited by this paper
• The prognostic value of troponin release after adult cardiac surgery - a meta-analysis.

  2009cited by this paper
• Troponin T elevation after implanted defibrillator discharge predicts survival

  2009cited by this paper
• Cardiac troponin I as prognostic marker in heart failure patients discharged from emergency department

  2008cited by this paper
• "Broken heart syndrome": catecholamine surge or aborted myocardial infarction?

  2008cited by this paper
• Cardiac troponin and outcome in acute heart failure.

  2008cited by this paper
• Takotsubo cardiomyopathy: pathogenetic insights and myocardial perfusion kinetics using myocardial contrast echocardiography.

  2008cited by this paper
• Persistently increased serum concentrations of cardiac troponin in patients with acutely decompensated heart failure are predictive of adverse outcomes.

  2007cited by this paper
• Relation between cardiac troponin I and mortality in acute decompensated heart failure.

  2007cited by this paper
• Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure

  2007cited by this paper
• A model for troponin I as a quantitative predictor of in-hospital mortality.

  2006cited by this paper
• Elevated troponin level is not synonymous with myocardial infarction.

  2006influential reference
• Significance of serum troponin I elevation in patients with acute aortic dissection of the ascending aorta

  2005cited by this paper
• Narrative Review: Alternative Causes for Elevated Cardiac Troponin Levels when Acute Coronary Syndromes Are Excluded

  2005cited by this paper
• Serial measure of cardiac troponin T levels for prediction of clinical events in decompensated heart failure.

  2004cited by this paper
• Ongoing Myocardial Injury in Stable Severe Heart Failure: Value of Cardiac Troponin T Monitoring for High-Risk Patient Identification

  2004cited by this paper
• Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial).

  2004cited by this paper
• Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis.

  2004cited by this paper
• Cardiac troponin I as a predictor of arrhythmia and ventricular dysfunction in trauma patients with myocardial contusion.

  2004cited by this paper
• Cardiac troponins

  2004cited by this paper
• Cardiac Troponin I Is Associated With Impaired Hemodynamics, Progressive Left Ventricular Dysfunction, and Increased Mortality Rates in Advanced Heart Failure

  2003cited by this paper
• Normal electrocardiography and serum troponin I levels preclude the presence of clinically significant blunt cardiac injury.

  2003influential reference
• Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins.

  2003cited by this paper
• Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure

  2003cited by this paper
• Clinical significance of serum cardiac troponin T in patients with congestive heart failure.

  2003cited by this paper
• Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure.

  2003cited by this paper
• Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure.

  2002cited by this paper
• Causes of elevated troponin I with a normal coronary angiogram.

  2002cited by this paper
• The cardiospecificity of the third-generation cTnT assay after exercise-induced muscle damage.

  2002cited by this paper
• Measurement of Cardiac Troponins

  2001cited by this paper
• Evaluation of incidence, clinical significance, and prognostic value of circulating cardiac troponin I and T elevation in hemodynamically stable patients with suspected myocardial contusion after blunt chest trauma.

  2000cited by this paper
• Cardiac troponin I as diagnostic and prognostic marker in severe heart failure.

  2000cited by this paper
• Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes.

  2000cited by this paper

• Performance evaluation of a new high-sensitivity cardiac troponin T assay: hs-cTnT (CLIA) assay

  2025cites this paper
• Cardiovascular biomarkers: exploring troponin and BNP applications in conditions related to carbon monoxide exposure

  2024cites this paper
• Evaluation of troponin I serum levels in patients with arrhythmias with and without coronary artery disease

  2023cites this paper
• A critical review on brain and heart axis response in COVID‐19 patients: Molecular mechanisms, mediators, biomarkers, and therapeutics

  2023cites this paper
• A Real Pandora’s Box in Pandemic Times: A Narrative Review on the Acute Cardiac Injury Due to COVID-19

  2022cites this paper
• Laboratory predictors of clinical outcomes in patients with atrial fibrillation

  2021cites this paper